ACOG Alpha Cognition Inc.
XNAS
8.73
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ACOG
$8.73
—
What changed
Recent filings, trades and movesKey stats
$8.73
- 52-Week Range
- $4.50 – $10.14
- YTD
- +34.31%
- Straddle Price
- $3.07
- P/C Vol Ratio
- 0.12
- Market Cap
- $0.2B
- Open
- $8.74
- Day Range
- $8.50 – $8.99
- Volume
- 107,835
- Prev Close
- $8.90
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.86% |
| Beta vs SPY | 1.62 |
| Cost of Equity (CAPM) | 13.77% (VRP-adj) |
| WACC | 13.84% |
| Volatility Risk Premium | +64.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -44.3% |
| Book / Price | 27.3% |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $8.78 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $8.55 |
| Bollinger Width / SMA20 | 14.1% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
60-Day Conviction
54%
20-Day Fair Value
≈ by Dec 10, 2026
$8.72
α -0.1%
rank 50%
conviction
10%
40-Day Fair Value
≈ by Jan 8, 2027
$8.88
α +1.8%
rank 44%
conviction
58%
60-Day Fair Value
≈ by Feb 8, 2027
$8.91
α +2.1%
rank 29%
conviction
54%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | n/a | 0% | |
| Peer P/S | n/a | 0% | |
| Market Anchor (SMA50) | $8.78 | 100% | stability 79% (BB-width) |
| Options Expected (B-L 30d) | $8.38 | 0% | 5 strikes · skew -0.23 |
As of 2026-11-11 · updated
Related
About
- Industry (SIC)
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
- Exchange
- XNAS
- Market Cap
- $0.2B
- Employees
- 71
- List Date
- 2021-06-09
- CIK
- 0001655923
- Next Earnings
- 2026-11-11 (After-Close)
- EPS Forecast
- ($0.34)
- Headquarters
- Grapevine, TX
- Homepage
- https://www.alphacognition.com
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking pote…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | -- | 0.88% | -25.54% | -12.33% |
| Feb | -- | 2.04% | 21.46% | 11.75% |
| Mar | -- | -7.66% | -5.34% | -6.50% |
| Apr | -- | 13.81% | 0.17% | 6.99% |
| May | -- | 56.02% | 4.03% | 30.03% |
| Jun | -- | -4.21% | 13.88% | 4.84% |
| Jul | -- | -0.98% | 6.84% | 2.93% |
| Aug | -- | -8.29% | 9.96% | 0.84% |
| Sep | -- | -20.12% | -1.85% | -10.99% |
| Oct | -- | -16.01% | 0.46% | -7.78% |
| Nov | 16.14% | 5.61% | 4.68%* | 8.81% |
| Dec | -3.44% | 15.04% | -- | 5.80% |
| Total | 12.14% | 19.68% | 23.19% | 18.34% |
* Only 3 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $8.55
SMA 50: $8.78
SMA 200: $7.24
Current: $8.73
EMA 12: $8.58
EMA 26: $8.64
MACD: -0.0556 | Signal: 0.0184
BEARISH
ADX (14): 14.49
RANGE
+DI: 21.38
−DI: 20.16
Momentum Oscillators
RSI (14): 51.40
NEUTRAL
Stoch %K: 48.30
Stoch %D: 35.92
Williams %R: -45.15
Volume & Volatility
BB Upper: $9.16
BB Lower: $7.95
NEUTRAL
OBV: 1,974,594
Vol SMA 20: 108,025
Vol ROC: -29.33%
ATR: $0.52
True Range: $0.49
HV 20: 57.2%
HV 30: 50.9%
HV 60: 48.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-12T00:00:00 – 2026-11-10T00:00:00
AI Analysis
LLM Stock Analysis Report: ACOG
Executive Summary
Overall assessment: NEUTRAL (confidence level: 6/10)
Key drivers:
- Recent earnings beats and positive news sentiment
- Bullish momentum signals from technical indicators
- Above-average volatility, potentially amplifying market moves
Primary risks:
- Volatility regime may amplify losses if price breaks down
- Earnings misses or negative news could lead to significant price declines
Investment thesis: ACOG's recent earnings beats and positive news sentiment have sparked bullish momentum. The stock's above-average volatility may amplify market moves, but also presents a risk of significant price declines.
Recent news sentiment impact: Positive news headlines have contributed to the stock's upward trend, with investors responding favorably to Alpha Cognition's Q1 2026 Earnings Transcript and OTC Markets Group's quarterly index performance announcement.
Technical Analysis
Trend Direction: Medium-term uptrend (1-3 months)
Support/Resistance Levels: Key levels to monitor:
- SMA 20: $9.20 (support)
- SMA 50: $8.60 (support)
- Upper Bollinger Band: $9.95 (resistance)
Momentum Signals:
- RSI interpretation: Neutral (58.11)
- MACD signal: Bullish (0.25 / Signal: -0.05 / Histogram: 0.30)
- Bollinger Bands position: Neutral
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 171621.61
- On-Balance Volume (OBV): 2514348.49
- Volume Rate of Change: -84.40%
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines have dominated the past few weeks, with investors responding favorably to Alpha Cognition's Q1 2026 Earnings Transcript and OTC Markets Group's quarterly index performance announcement.
Sentiment Assessment: Aggregate news sentiment: POSITIVE
Catalyst Identification: Upcoming earnings release for Q2 2026 may provide a significant catalyst for the stock price.
Market Narrative: Positive news headlines have aligned with bullish momentum signals from technical indicators, creating an upward trend in the stock price.
Risk & Volatility Assessment
Beta Interpretation: Beta: 1.04 (vs SPY), indicating above-average volatility and potential amplification of market moves.
Volatility Regime: Current vs historical volatility levels:
- Historical Volatility: HV20 48.5% / HV30 57.4% / HV60 55.9%
- IV Premium vs HV30: N/A (positive = implied richer than realized)
Options Market Signals: No options data available.
Downside Protection: Support levels and risk management considerations:
- SMA 20: $9.20 (support)
- SMA 50: $8.60 (support)
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- Alpha Cognition's industry/sector has performed relatively well, contributing to the stock's upward trend.
Institutional Activity: Volume patterns suggesting institutional interest signals:
- On-Balance Volume (OBV): 2514348.49
- Volume Rate of Change: -84.40%
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- Correlation: 0.20, indicating a moderate correlation between the stock price and broader market.
Relative Valuation: Position within trading range:
- The stock is positioned in the upper end of its trading range, suggesting potential for further upward movement or a correction back towards support levels.
Key Levels & Action Items
Critical Price Levels: Support/resistance to monitor:
- SMA 20: $9.20 (support)
- SMA 50: $8.60 (support)
- Upper Bollinger Band: $9.95 (resistance)
Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
- SMA 200: $6.61 (breakdown level)
Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:
- Q2 2026 earnings release may provide a significant catalyst for the stock price.
Risk Management: Stop-loss levels and position sizing considerations:
- Set stop-loss at SMA 20: $9.20 to manage potential downside risk.
- Consider adjusting position size based on market volatility and news sentiment.
Please note that this analysis is based solely on the provided data, and actual results may vary. The report provides a comprehensive overview of the stock's technical and fundamental factors, as well as recent news headlines and market conditions.
Generated
News
All ACOG news →
ACOG Options Activity & IV Rank
Volatility Metrics
Current IV: —
7-DTE IV: —
Expected Move: $3.07
7-DTE Move: $3.05
Days to Exp: 38 (2026-12-18)
Options Flow · All expiries
Call Volume: 518
Put Volume: 62
P/C Volume: 0.12
BULLISH
Call OI: 690
Put OI: 179
P/C OI: 0.259
Total OI: 869
ATM Options Pricing
ATM Call: $2.55
ATM Put: $0.53
Call %: 29.2%
Put %: 6.0%
Chain Summary
Chain Volume: 580
Chain OI: 869
Last Updated: 11/10/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 71st percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
71%
vs own history
GEX tilt
+0.95
OI-weighted, today
Vanna tilt
+0.89
δ-sensitivity to IV
Charm tilt
-0.99
δ-decay vs time
Vanna tilt +0.89: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.99: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 3 ATM contracts, 1k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Nov 10 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Nov 10 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$3.07Nov 10
Beta Analysis
Risk Metrics
Beta: 1.1194
Alpha: 41.05%
Correlation: 0.2434
R-Squared: 5.9%
Stock Volatility: 62.9%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Notable investors who own ACOG
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $704K | #4100 of 6285 | +8.9% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ACOG Institutional Ownership (13F)
Filings for 2026-06-30 · 9 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
1 filers$1.80K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $1.80K | 100.00% | 2026-09-30 |
1 filers$27.00K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $27.00K | 100.00% | 2026-09-30 |
ACOG Insider Trading (Form 4)
Latest: 2026-10-26Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +32,090 | $8.28 | $265.8K | EDGAR |
| 2026-10-19 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +36,940 | $8.35 | $308.6K | EDGAR |
| 2026-10-02 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +19,050 | $8.69 | $165.6K | EDGAR |
| 2026-09-28 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +31,763 | $8.53 | $270.8K | EDGAR |
| 2026-09-16 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +123,918 | $8.57 | $1.06M | EDGAR |
| 2026-08-24 | Robert James Wills | Director | Buy (P) | +10,000 | $9.62 | $96.2K | EDGAR |
| 2026-08-04 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +52,900 | $8.00 | $423.0K | EDGAR |
| 2026-07-28 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +130 | $7.90 | $1.0K | EDGAR |
| 2026-07-24 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +200,086 | $7.82 | $1.57M | EDGAR |
| 2026-06-29 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +152,533 | $6.40 | $976.5K | EDGAR |
| 2026-06-15 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +7,685 | $5.96 | $45.8K | EDGAR |
| 2026-06-11 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +30,728 | $5.98 | $183.7K | EDGAR |
| 2026-06-09 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +10,054 | $5.83 | $58.6K | EDGAR |
| 2026-05-29 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +73,738 | $5.90 | $434.7K | EDGAR |
| 2026-05-22 | Opaleye Management Inc. | 10%+ Owner | Buy (P) | +24,376 | $5.77 | $140.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ACOG Insider Holdings
10 insiders · @ $8.73
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Leonard Powell Mertz | Director | 267,239 | $2.33M | $250.0K | 3 | 2026-01-16 |
| 2 | Michael E. McFadden | Chief Executive Officer | 204,691 | $1.79M | $0 | 2 | 2026-01-13 |
| 3 | Kenneth Anthony Cawkell | Director | 175,717 | $1.53M | $0 | 2 | 2026-01-16 |
| 4 | Lauren D'Angelo | Chief Operating Officer | 140,695 | $1.23M | $20.2K | 3 | 2026-05-19 |
| 5 | Opaleye Management Inc. | 10%+ Owner | 100,000 | $873.0K | $8.17M | 24 | 2026-10-26 |
| 6 | Phillip Joseph Mertz | Director | 42,263 | $369.0K | -$250.0K | 3 | 2026-01-16 |
| 7 | Robert James Wills | Director | 32,241 | $281.5K | $223.5K | 4 | 2026-08-24 |
| 8 | Huy Du Henry | VP Finance and Accounting | 20,579 | $179.7K | $0 | 1 | 2026-01-13 |
| 9 | Rajeev Kumar Bakshi | Director | 19,084 | $166.6K | $0 | 2 | 2026-01-16 |
| 10 | Bethany Sensenig | Director | 5,489 | $47.9K | $0 | 1 | 2026-04-17 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ACOG Board & Officers
As of SEC filings through Oct 26, 2026Directors 6
- Kenneth Anthony Cawkell · since Nov 12, 2024
- Michael E. McFadden · since Nov 12, 2024
- Phillip Joseph Mertz · since Nov 12, 2024
- Rajeev Kumar Bakshi · since Nov 12, 2024
- Robert James Wills · since Apr 7, 2025
- Bethany Sensenig · since Apr 15, 2026
Officers 3
- Michael E. McFadden · Chief Executive Officer · since Nov 12, 2024
- Lauren D'Angelo · Chief Operating Officer · since Nov 12, 2024
- Huy Du Henry · VP Finance and Accounting · since Nov 12, 2024
10% owners 1
- Opaleye Management Inc. (entity) · since Feb 19, 2026
Changes in the last 10 years (14)
| Apr 15, 2026 | Bethany Sensenig became a director |
| Feb 19, 2026 | Opaleye Management Inc. became a 10% owner |
| Feb 18, 2026 | The company announced the departure of Leonard Powell Mertz from the board in an SEC filing |
| Apr 7, 2025 | The company announced the departure of John Prentiss Havens from the board in an SEC filing |
| Apr 7, 2025 | Robert James Wills became a director |
| Nov 12, 2024 | Rajeev Kumar Bakshi became a director |
| Nov 12, 2024 | Phillip Joseph Mertz became a director |
| Nov 12, 2024 | Michael E. McFadden became a director |
| Nov 12, 2024 | Michael E. McFadden became Chief Executive Officer |
| Nov 12, 2024 | Leonard Powell Mertz became a director |
| Nov 12, 2024 | Lauren D'Angelo became Chief Operating Officer |
| Nov 12, 2024 | Kenneth Anthony Cawkell became a director |
| Nov 12, 2024 | John Prentiss Havens became a director |
| Nov 12, 2024 | Huy Du Henry became VP Finance and Accounting |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
Recent SEC Filings
Latest: 2026-08-13
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-06-23 | Director or officer change · Shareholder vote results | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-13 | 0001213900-26-089188 | EDGAR |
ETF Holders
1 ETF hold ACOG
1 shown · $115.42K total exposure · 0.00% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.00% | $115,424 | $3.2B | 2026-11-09 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
3.66
P/S
12.70
EV/EBITDA
-5.27
EV/Sales
9.99
ROE
-44.3%
ROA
-36.3%
Div Yield
0.00%
FCF Yield
-16.08%
Debt/Equity
0.00
Current Ratio
9.03
Market Cap
$193.82M
as of 2026-11-09
ACOG vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc | $251.6B | 27.0 | +8.2% | +42.0% | 36 |
| GILD Gilead Sciences Inc | $210.0B | — | +6.5% | +40.5% | 43 |
| MRNA Moderna, Inc. Common Stock | $108.8B | — | −27.6% | +712.8% | 47 |
| ARGX argenx SE American Depositary Shares | $60.5B | — | — | +15.7% | 58 |
| RVMD Revolution Medicines, Inc. Common Stock | $43.3B | — | — | +144.3% | 60 |
| BIIB Biogen Inc. Common Stock | $37.7B | 108.2 | +2.3% | +42.4% | 97 |
| BNTX BioNTech SE American Depositary Share | $21.7B | — | — | −9.8% | 31 |
| EXEL Exelixis Inc | $17.5B | 21.1 | +9.1% | +62.0% | 19 |
| ACOG Alpha Cognition Inc. Common Stock | $194M | — | — | +34.3% | — |
| Peer median | $51.9B | 27.0 | +6.5% | +42.2% | 45 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
352.52K
SI % of Float
1.77%
Days to Cover
3.79
Short Vol Ratio
36.9%
Free Float
19.92M
Float %
91.5%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-09-23